Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akpek

Showing results (401-410 of 428) with videos related to

Pageof 43
Sort By:
Bone Marrow Transplantation|April 28, 2015
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomeS D Goyal, M-J Zhang, H-L Wang, et al.
The Ocular Surface|November 10, 2015
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic DiseaseSahar Kohanim, Sotiria Palioura, Hajirah N Saeed, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
The Ocular Surface|February 18, 2016
Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic DiseaseSahar Kohanim, Sotiria Palioura, Hajirah N Saeed, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2015
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection CentersBronwen E Shaw, Brent R Logan, Deidre M Kiefer, et al.
Frontiers in Immunology|September 20, 2021
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 TrialPolina Shindiapina, Maciej Pietrzak, Michal Seweryn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2018
Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between GroupsEmma C Scott, Parameswaran Hari, Sathish Kumar, et al.
Cornea|November 15, 2017
Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic PossibilitiesClaes H Dohlman, Fabiano Cade, Caio V Regatieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic SyndromesAaron T Gerds, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2015
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic AnemiaYoshihiro Inamoto, Mary E D Flowers, Tao Wang, et al.
Pageof 43

Showing results (401-410 of 428) with videos related to

Sort By:
Pageof 43
Bone Marrow Transplantation|April 28, 2015
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomeS D Goyal, M-J Zhang, H-L Wang, et al.
The Ocular Surface|November 10, 2015
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic DiseaseSahar Kohanim, Sotiria Palioura, Hajirah N Saeed, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
The Ocular Surface|February 18, 2016
Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic DiseaseSahar Kohanim, Sotiria Palioura, Hajirah N Saeed, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2015
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection CentersBronwen E Shaw, Brent R Logan, Deidre M Kiefer, et al.
Frontiers in Immunology|September 20, 2021
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 TrialPolina Shindiapina, Maciej Pietrzak, Michal Seweryn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2018
Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between GroupsEmma C Scott, Parameswaran Hari, Sathish Kumar, et al.
Cornea|November 15, 2017
Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic PossibilitiesClaes H Dohlman, Fabiano Cade, Caio V Regatieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic SyndromesAaron T Gerds, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2015
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic AnemiaYoshihiro Inamoto, Mary E D Flowers, Tao Wang, et al.
Pageof 43